Sprint Bioscience AB (publ) (STO:SPRINT)

Sweden · Delayed Price · Currency is SEK

3.480

+0.060 (1.75%)

May 21, 2026, 1:30 PM CET

Revenue by Segment

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Biotechnology	167.39M	66.14M	51.69M	83.00K	35.03M
Biotechnology Growth	153.07%	27.97%	62171.08%	-99.76%	82.49%
Total	167.39M	66.14M	51.69M	83.00K	35.03M
Total Growth	153.07%	27.97%	62171.08%	-99.76%	82.49%

Revenue by Geography

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Sweden	6.00K	16.00K	41.00K	48.00K	-
Sweden Growth	-62.50%	-60.98%	-14.58%	-	-
USA	167.16M	65.63M	50.45M	35.00K	35.11M
USA Growth	154.72%	30.09%	144028.57%	-99.90%	-
Total	167.17M	65.64M	50.49M	83.00K	35.11M
Total Growth	154.67%	30.02%	60726.51%	-99.76%	107.96%

Source: S&P Global Market Intelligence.